United States of America. The Drug Enforcement Administration has proposed to remove a drug product containing the cannabinoid derivative, dronabinol (Marinol; delta⁹-(trans)-tetrahydrocannabinol) in sesame oil and encapsulated in soft gelatin capsules, from Schedule II and place it into Schedule III of the Controlled Substances Act.

Dronabinol is internationally controlled in Schedule II of the 1971 Convention on Pyschotropic Substances. Because of this, an import/export permit will still be required for dronabinol.

Reference: Federal Register 63(214): 59751-53 (1998).